Acetyl chloride → HCID 86716121, compound

HRID 627556Notes

Reaction equation

HRID 627556 reaction equation
[Cl:1][C:2]1[C:11]([C:12]2[CH:17]=[CH:16][CH:15]=[CH:14][CH:13]=2)=[C:10]([Cl:18])[C:9]2[C:4](=[CH:5][CH:6]=[C:7]([C:19]([OH:39])([C:33]3[CH:34]=[N:35][CH:36]=[CH:37][CH:38]=3)[CH:20]3[CH2:25][CH2:24][N:23]([C:26](OC(C)(C)C)=[O:27])[CH2:22][CH2:21]3)[CH:8]=2)[N:3]=1.[C:40]([OH:46])([C:42]([F:45])([F:44])[F:43])=[O:41].C(Cl)(=O)C.CCN(CC)CC>C(Cl)Cl>[C:26]([N:23]1[CH2:22][CH2:21][CH:20]([C:19]([C:7]2[CH:8]=[C:9]3[C:4](=[CH:5][CH:6]=2)[N:3]=[C:2]([Cl:1])[C:11]([C:12]2[CH:13]=[CH:14][CH:15]=[CH:16][CH:17]=2)=[C:10]3[Cl:18])([C:33]2[CH:34]=[N:35][CH:36]=[CH:37][CH:38]=2)[OH:39])[CH2:25][CH2:24]1)(=[O:27])[CH3:40].[C:40]([OH:46])([C:42]([F:45])([F:44])[F:43])=[O:41]

Participants

6

Procedure

tert-Butyl 4-[(2,4-dichloro-3-phenylquinolin-6-yl)(hydroxy)pyridin-3-ylmethyl]piperidine-1-carboxylate (149 mg, 0.264 mmol, Example 91) was treated with TFA (1 mL) at room temperature for 1 hour and concentrated. A part of the residue (10 mg, 0.027 mmol), acetyl chloride (10 mg, 0.13 mmol), and Et3N (0.030 mL, 0.22 mmol) in CH2Cl2 (1 mL) was stirred overnight and concentrated. The residue was purified by reverse phase HPLC (water/acetonitrile/0.1% TFA) to provide the title compound as a white solid. 1H NMR (400 MHz, MeOH-d4) δ 9.11 (s, 1H), 8.80 (t, J=7.33 Hz, 1H), 8.70 (d, J=5.56 Hz, 1H), 8.59-8.65 (m, 1H), 8.08-8.15 (m, 1H), 8.01-8.06 (m, 1H), 7.94-8.01 (m, 1H), 7.47-7.57 (m, 3H), 7.33 (t, J=6.57 Hz, 2H), 4.59 (d, J=13.14 Hz, 1H), 3.97 (d, J=13.14 Hz, 1H), 3.10-3.28 (m, 2H), 2.63-2.76 (m, 1H), 1.37-1.67 (m, 4H); MS m/e 506.1 [M+H]+.

Workup

  1. concentrationconcentrated
  2. concentrationconcentrated
  3. customThe residue was purified by reverse phase HPLC (water/acetonitrile/0.1% TFA)

Sources & evidence

ORD record
ord-adc22b5fbec1445c938660b6295dcd67
Source dataset
uspto-grants-2016_04
Patent number
US09309222B2

Reaction notes

Loading…